Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-08

Clinical Trial Update: Menthol for Improving Movement and Sleep in Parkinson's Disease Patients [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on menthol for improving movement and sleep in Parkinson's disease; study status is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Menthol (menthol)

Snippet

Sponsor: Taipei Medical University Hospital | Conditions: Parkinson's Disease | Phase 2 | Status: NOT_YET_RECRUITING